期刊文献+

散发性乳腺癌中BRCA1基因甲基化状态与其mRNA表达水平的相关研究 被引量:8

Study in BRCA1 gene methylation status and mRNA expression level in sporadic breast cancer
下载PDF
导出
摘要 目的:探讨山东半岛地区散发性乳腺癌中BRCA1基因异常甲基化状态及其与mRNA表达的关系,进而研究其BRCA1基因异常的表观遗传学作用。方法:用甲基化特异性PCR和RT-PCR等方法研究乳腺癌组织、癌旁正常组织及乳腺良性肿瘤中BRCA1基因启动子甲基化状态及其mRNA表达水平。结果:在30例散发性乳腺癌中,BRCA1基因甲基化率为43%,BRCA1 mRNA表达下降率为33%。在13例BRCA1发生甲基化的癌组织标本中,BRCA1 mRNA的表达下降率为55%,而在17例BRCA1未发生甲基化的癌组织中,BRCA1 mRNA的表达下降率为18%。在肿瘤分级中,T3分级病人的肿瘤组织中BRCA1甲基化率(74%)和mRNA表达下降率(54%),均分别高于T1+T2分级病人肿瘤组织的BRCA1甲基化率(26%)和mRNA表达下降率(30%);有淋巴结转移病人的肿瘤组织中,BRCA1甲基化率(61%)和mRNA表达下降率(46%),均分别高于无淋巴结转移的甲基化率(17%)和mRNA表达下降率(16%)。结论:BRCA1基因表观遗传学改变是其mRNA表达下降乃至失活的重要原因,且与散发性乳腺癌的恶性程度及淋巴结转移的发生密切相关。 Objective To investigate the relationship between the abnormal methylation condition of BRCA1 gene in sporadic breast cancer and the changes in the expression level of its mRNA in the region of Shandong peninsula;study in the abnormal epigenetical role of BRCA1 gene in sporadic breast cancer.Methods To research the methylation status of BRCA1 gene promoter and the changes in the expression level of its mRNA in breast cancer tissue,corresponding adjacent normal tissue and benign breast tumor tissue with the methylation-specific PCR and RT-PCR methods.Results In 30 cases with sporadic breast cancer,the methylation rate of BRCA1 gene was 43%,and the decrease in expression rate was 33%;the expression rate dropped to 55% in 13 cases with cancerous tissue samples with BRCA1 methylation,while the rate of unmethylated cases(17 cases) was 18%.In relation to the classification of the tumor,the BRCA1 methylation rate was 74% in the tumor tissue of cases belonging to grade T3,which was higher than the total rate of 26% in grades of T1 and T2;while the mRNA expression rate of decline(54%) was also higher than the total rate of 30% in grades T1 and T2 patients.The BRCA1 methylation rate(61%) and the declination rate of mRNA expression in patients with lymph node metastasis(46%) were higher than both the corresponding rates(17% and 16%) in patients without lymph node metastasis.Conclusions The declination or inactivation of BRCA1 mRNA expression may be due to the epigenetic change in the BRCA1 gene,which is closely related to the grade of malignancy in sporadic breast cancer and the associated lymph node metastasis.
出处 《外科理论与实践》 2011年第6期576-580,共5页 Journal of Surgery Concepts & Practice
基金 山东省自然科学基金(009ZRB14999)
关键词 BRCA1基因 DNA甲基化 逆转录-聚合酶链反应 甲基化特异性 散发性乳腺癌 BRCA1 gene DNA methylation RT-PCR Methylation-specific polymerase chain reaction Sporadic breast cancer
  • 相关文献

参考文献13

  • 1张建,邢雪,韩宏光,葛忠.血管紧张素Ⅱ诱导VEGFmRNA在人肝癌细胞中的表达[J].中国普通外科杂志,2010,19(2):159-163. 被引量:7
  • 2Grushko TA, Dignam JJ, Das S, et al. MYC is amplified in BRCAl-associated breast cancers[J]. Clin Cancer Res, 2004,10(2):499-507.
  • 3Herman JG, Graft JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci U S A,1996,93(18): 9821-9826.
  • 4冯景,张吉才,陶建蜀,吕军,付萍,郭建华,周有利.散发性乳腺癌患者血浆BRCA1基因启动子异常甲基化的检测[J].中国癌症杂志,2005,15(5):442-445. 被引量:14
  • 5Futreal PA, Liu Q, Shattuck-Eidens D, et al. BRCAI mutations in primary breast and ovarian carcinomas [J]. Science, 1994,266(5182): 120-122.
  • 6Cropp CS, Nevanlinna HA, Pyrhonen S, et al. Evidence for involvement of BRCA1 in sporadic breast carcinomas [J]. Cancer Res,1994,54(10):2548-2551.
  • 7Jeronimo C, Costa I, Martins MC, et al. Detection of gene promoter hypermethylation in fine needle washings from breast lesions[J]. Clin Cancer Res,2003,9(9):3413-3417.
  • 8Ibanez de Caceres I, Battagli C, Esteller M, et al. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients[J]. Cancer Res,2004,64(18):6476-6481.
  • 9Rice JC, Ozcelik H, Maxeiner P, et al. Methylation of the BRCAI promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens [J]. Carcinogenesis,2000,21 (9): 1761-1765.
  • 10任婕,魏敏杰,金锋,杨栋,林哲珠,马文峰,金万宝.散发性乳腺癌组织中BRCA1基因启动子甲基化与蛋白表达的相关性[J].中华肿瘤防治杂志,2007,14(3):161-164. 被引量:12

二级参考文献33

  • 1Giuseppe ZARDO,Francesco FAZI,Lorena TRAVAGLINI,Clara NERVI.Dynamic and reversibility of heterochromatic gene silencing in human dis-ease[J].Cell Research,2005,15(9):679-690. 被引量:5
  • 2黄玮,钟捷.血管紧张素Ⅱ及其受体1在实体肿瘤中的研究进展[J].肿瘤,2007,27(2):162-163. 被引量:3
  • 3廖艳丹,徐弘,韩庆,雷婕,张颖颖,王泽华.宫颈鳞癌组织与细胞系中血管紧张素Ⅱ-1型受体的表达及其临床意义[J].中华肿瘤杂志,2007,29(5):360-364. 被引量:9
  • 4Rousseau S, Houle F, Landry J, et al. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and eenmigration in human endothelial cells [J]. Onto gene, 1997, 15 (18): 2169-2175.
  • 5Levera F, Holed J, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer [J]. Lancet, 1998, 352 (9123) : 179 -184.
  • 6Suganuma T, Ino K, Shibata K, et al. Functional expression of the Angiotensin Ⅱ type Ⅰ receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination [J]. Clin Cancer Res,2005,11 (7) :2686 -2694.
  • 7Brown RE, Siegelmann DN, Zhang PL, et al. Morphop roteomic confirmation of an overexpressed angiotensin system in invasive breast carcinoma [ J ]. Ann Clime Lab Sci, 2006, 36(2) :225 -226.
  • 8Yoshiji H, Yoshii J. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells[J]. Int J Oncol, 2002, 20(6) :1227 - 1231.
  • 9Hash lmoto G, Inoki I, Fuji Y, et al. Matrixmetallop roteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165 [J]. J Biol Chem, 2002, 277 (39) : 36288 - 36295.
  • 10Won SM, Park YH, Kim H J, et al. Catechins inhibit angiotensin II-induced vascular smooth muscle cell proliferation via mitogen-activated protein kinase pathway [ J ]. Exper Molec Med, 2006, 38(5) : 525 -534.

共引文献34

同被引文献80

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部